Novo Nordisk’s Wegovy approved in China as weight-loss drug race heats up
Wegovy, the weight-loss drug developed by Novo Nordisk, was approved for sale in China, opening up a new frontier for the Danish pharmaceutical company. The firm’s stock reached a record high both in Denmark and the US in the hours after the announcement.